Medical Condition News

RSS

New study casts doubt on the effectiveness of brief counseling for illicit drug use

In an effort to stem substance use, the U.S. has invested heavily in the past decade in a brief screening-and-intervention protocol for alcohol and other drugs.

7 Aug 2014

Novel therapy takes rheumatoid arthritis treatment in mice to a new level

Rheumatoid arthritis is a condition that causes painful inflammation of several joints in the body. The joint capsule becomes swollen, and the disease can also destroy cartilage and bone as it progresses. Rheumatoid arthritis affects 0.5% to 1% of the world's population. Up to this point, doctors have used various drugs to slow or stop the progression of the disease.

7 Aug 2014

UH Case Medical Center implants new type of cochlear device in patients with hearing problem

University Hospitals Case Medical Center is the first in Cleveland to implant a new type of cochlear device for adults who have lost the high frequency range of their hearing, but have retained the low frequencies with or without a hearing aid.

7 Aug 2014

MIT researchers generate liver tumors in adult mice

Sequencing the genomes of tumor cells has revealed thousands of mutations associated with cancer. One way to discover the role of these mutations is to breed a strain of mice that carry the genetic flaw — but breeding such mice is an expensive, time-consuming process.

7 Aug 2014

Prompt administration of alteplase treatment reduces disability in stroke patients

Many more stroke patients could benefit from thrombolytic treatment (the use of drugs to break up or dissolve blood clots), but it needs to be administered as quickly as possible after the first signs of illness, according to new findings from the largest meta-analysis to date investigating the clot-busting drug alteplase.

7 Aug 2014

CTI BioPharma's pacritinib granted FDA Fast Track designation for treatment of myelofibrosis

CTI BioPharma Corp. announced today that pacritinib has been granted Fast Track designation by the U.S. Food and Drug Administration for the treatment of intermediate and high risk myelofibrosis, including but not limited to patients with disease related thrombocytopenia, patients experiencing treatment emergent thrombocytopenia on other JAK2 therapy or patients who are intolerant to or whose symptoms are sub-optimally managed on other JAK2 therapy.

7 Aug 2014

Low levels of vitamin D may double dementia, Alzheimer's risks

In the largest study of its kind, researchers suggests that in older people, not getting enough vitamin D may double the risk of developing dementia and Alzheimer's disease. The study is published in the August 6, 2014, online issue of Neurology, the medical journal of the American Academy of Neurology.

7 Aug 2014

UMass Amherst researcher receives grant to uncover molecular mechanisms of skeletal muscle fatigue

Muscle physiologist Edward Debold at the University of Massachusetts Amherst's School of Public Health and Health Sciences recently received a three-year, $198,000 grant from the American Heart Association to support studies to uncover the molecular mechanisms of skeletal muscle fatigue.

7 Aug 2014

UCSF researchers identify novel molecular features within the developing human brain

UC San Francisco researchers have identified cells' unique features within the developing human brain, using the latest technologies for analyzing gene activity in individual cells, and have demonstrated that large-scale cell surveys can be done much more efficiently and cheaply than was previously thought possible.

7 Aug 2014

Long-term survival from pancreatic cancer fails to improve in 40 years

Long-term survival from pancreatic cancer has failed to improve in 40 years - with the outlook remaining the lowest of the 21 most common cancers, according to new figures published by Cancer Research UK today.

7 Aug 2014

Study: Aggressive behaviour linked to increased alcohol use among adolescents

Adolescents who behave aggressively are more likely to drink alcohol and in larger quantities than their peers, according to a recent study completed in Finland. Depression and anxiety, on the other hand, were not linked to increased alcohol use.

7 Aug 2014

New reporting standards proposed for spinal cord injury experiments

The difficulty in replicating and directly comparing and confirming the scientific results reported by researchers worldwide who are studying new approaches to treating spinal cord injuries is slowing the translation of important new findings to patient care.

7 Aug 2014

Immunosuppressive drugs increase risk of myeloid disorders among IBD patients

Immunosuppressive drugs called thiopurines have been found to increase the risk of myeloid disorders, such as acute myeloid leukemia and myelodysplastic syndrome, a rare bone marrow disorder, seven-fold among inflammatory bowel disease (IBD) patients.

7 Aug 2014

Findings show how galectin-1 protein plays key role in high grade malignant gliomas

Brain tumors fly under the radar of the body's defense forces by coating their cells with extra amounts of a specific protein, new research shows.

7 Aug 2014

Researchers take major step forward in developing real ALS treatments

A series of studies begun by Harvard Stem Cell Institute scientists eight years ago has lead to a report published today that may be a major step forward in the quest to develop real treatments for amyotrophic lateral sclerosis, ALS, or Lou Gehrig's disease.

7 Aug 2014

Induced immunorejection may eliminate tumors post-cell transplantation

Recent studies have shown that transplanting induced pluripotent stem cell-derived neural stem cells (iPS-NSCs) can promote functional recovery after spinal cord injury in rodents and non-human primates. However, a serious drawback to the transplantation of iPS-NSCs is the potential for tumor growth, or tumorogenesis, post-transplantation.

7 Aug 2014

Altering the circadian rhythm: an interview with Dr. Doug Kojetin, The Scripps Research Institute

The circadian rhythm is affected by many different stimuli—such as sleep and light, which are the most broadly appreciated ways—but also eating— all of which can modulate, or change, important processes in our bodies such as temperature, production of hormones or other signalling small molecules, cellular regeneration, and others.

6 Aug 2014

BD Medical announces retail pharmacy launch of BD AutoShield Duo

BD Medical, a segment of BD (Becton, Dickinson and Company), a leading global medical technology company, today announced the retail pharmacy launch of BD AutoShield Duo, the only pen needle with patented dual front and back-end shields that provides greater convenience and safety before and after injecting.

From BD (Becton, Dickinson and Company) 6 Aug 2014

BioDelivery Sciences updates on Clonidine Topical Gel Phase 3 trial for PDN treatment

BioDelivery Sciences International, Inc. announced today that it has completed a pre-specified interim analysis of the ongoing initial pivotal Phase 3 trial for Clonidine Topical Gel for the treatment of painful diabetic neuropathy (PDN).

6 Aug 2014

New probe can be used in 3 unique ways to detect cancer

As thousands of vacationers hit the beach this summer, many of them will expose their unprotected bare limbs to direct UV sunlight, potentially putting them at risk of skin cancer later in life.

6 Aug 2014

Medical Condition News

New study casts doubt on the effectiveness of brief counseling for illicit drug use

Novel therapy takes rheumatoid arthritis treatment in mice to a new level

UH Case Medical Center implants new type of cochlear device in patients with hearing problem

MIT researchers generate liver tumors in adult mice

Prompt administration of alteplase treatment reduces disability in stroke patients

CTI BioPharma's pacritinib granted FDA Fast Track designation for treatment of myelofibrosis

Low levels of vitamin D may double dementia, Alzheimer's risks

UMass Amherst researcher receives grant to uncover molecular mechanisms of skeletal muscle fatigue

UCSF researchers identify novel molecular features within the developing human brain

Long-term survival from pancreatic cancer fails to improve in 40 years

Study: Aggressive behaviour linked to increased alcohol use among adolescents

New reporting standards proposed for spinal cord injury experiments

Immunosuppressive drugs increase risk of myeloid disorders among IBD patients

Findings show how galectin-1 protein plays key role in high grade malignant gliomas

Researchers take major step forward in developing real ALS treatments

Induced immunorejection may eliminate tumors post-cell transplantation

Altering the circadian rhythm: an interview with Dr. Doug Kojetin, The Scripps Research Institute

BD Medical announces retail pharmacy launch of BD AutoShield Duo

BioDelivery Sciences updates on Clonidine Topical Gel Phase 3 trial for PDN treatment

New probe can be used in 3 unique ways to detect cancer

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News